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A high plasma carotenoid concentration could improve the immune response and result in decreased risk of infectious diseases. However,
data on the relationship of plasma carotenoid concentration with acute respiratory infections, which occur frequently in elderly people, are
scarce. We investigated, therefore, the relationship of plasma concentrations of six major carotenoids (b-carotene, a-carotene, b-crypto-
xanthin, lycopene, lutein and zeaxanthin) with the incidence and severity of acute respiratory infections. Baseline data from an intervention
trial were used. Participants were 652 non-institutionalized elderly people ($60 years old) enrolled via two community-based sampling
strategies in the Wageningen area of The Netherlands in 1998–99. Plasma carotenoid concentrations were divided into quartiles, the
lowest being the reference. Frequency and severity of episodes during the previous 1 year, i.e. staying in bed, medical consultation
and episode-related medication, were self-reported by means of a questionnaire. On average 1·6 episodes per person were recorded.
The incidence rate ratio of acute respiratory infections at high b-carotene status was 0·71 (95 % CI 0·54–0·92) as compared with the
low b-carotene concentration group. No association was observed between b-carotene and illness severity. a-Carotene, b-cryptoxanthin,
lycopene, lutein and zeaxanthin were not related to incidence or severity of the infections. We conclude that elderly people with a high
plasma b-carotene concentration may have a lower occurrence of acute respiratory infections.
Acute respiratory infection: Carotenoids: Elderly people
Elderly people are at high risk of morbidity from infections,
especially from respiratory infections, which occur fre-
quently (Miller, 1996). On average, community-dwelling
elderly people suffer from one to two acute respiratory
infections per year (Nicholson et al. 1997; Graat et al. 2002).
b-Carotene, a-carotene, b-cryptoxanthin, zeaxanthin,
lycopene and lutein comprise approximately 90 % of the
total plasma pool of carotenoids (Thurnham, 1994; Vogel
et al. 1997). b-Carotene has been studied extensively in
relation to immune response, whereas for other carotenoids
such information is scarce (Jyonouchi et al. 1996; Hughes
et al. 2000; Corridan et al. 2001). Some studies have
shown an enhanced immune response at high plasma b-
carotene status or after b-carotene supplementation
(Watson et al. 1991; Fuller et al. 1992; van-Poppel et al.
1993; Murata et al. 1994; Santos et al. 1996; Hughes,
2001), whereas others have not (Ringer et al. 1991;
Daudu et al. 1994; Murata et al. 1994; Santos et al.
1997; Corridan et al. 2001). Only one study has investi-
gated acute respiratory infections, i.e. common cold inci-
dence, in relation to both dietary b-carotene intake and
supplementation in male smokers. High intake was associ-
ated with a slightly higher cold incidence, whereas sup-
plementation had no effect on incidence (Hemila et al.
2002). The antioxidant properties and modulating effect
on prostaglandin E2 production of b-carotene might
explain its possible beneficial effects (Khachik et al.
1995; Hughes, 2001).
Although clinical endpoints such as infectious diseases
have much greater public health relevance than immune
function, they have hardly been studied until now. The
aim of our present study was to investigate the relationship
between plasma carotenoid concentrations and acute res-
piratory infections during 1997–98 in elderly persons.
We investigated the incidence of illness and severity in
relation to b-carotene, a-carotene, b-cryptoxanthin, lyco-
pene, lutein and zeaxanthin.
Methods
Subjects
Subjects were approached to participate in a 15-month
double-blind intervention trial investigating the effect of
daily micronutrients on acute respiratory infections. Accord-
ing to the 2 £ 2 factorial design, participants were randomly
assigned to the following groups using blocked randomiz-
ation: 200 mg d1-a-tocopheryl acetate; a physiological
dose of multivitamins–minerals; 200 mg d1-a-tocopheryl
acetate plus a physiological dose of multivitamins–minerals;
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placebo. The present study has been described in detail by
Graat et al. (2002).
We used the baseline information of our present study
population for this retrospective study concerning caroten-
oid status and respiratory infections in the previous 1 year.
The study population included 652 participants: 325 men
and 327 women. All persons were $60 years old, with
an average age of 73 years. Only 2 % of the subjects
lived in homes for the aged. We therefore consider that
our present study population were non-institutionalized.
Participants had no history of cancer, liver disease or fat
malabsorption in the 5 years before enrolment. A question-
naire was used to ask for nutritional supplementation
during the previous year. Written informed consent was
obtained from all participants before participation. The
medical ethics committee of Wageningen University,
The Netherlands, approved the research protocol.
Respiratory infections
The main outcomes were incidence and severity of acute
respiratory infections during the previous year. At the
time of blood collection, which was between 1 September
1998 and 23 March 1999, a detailed questionnaire about
respiratory infections during the previous 12 months was
filled out by all participants, with the help of a research
assistant. Therefore, the recorded infections took place in
1997–98. Participants were asked about the frequency of
common cold, influenza, pneumonia, sore throat and pain
in facial sinuses. These different manifestations of infec-
tion were combined and simply referred to as ‘acute respir-
atory infection’ for two reasons: (1) it is difficult to
distinguish between upper and lower respiratory infections,
because the symptom patterns can be indistinguishable
(Tannock et al. 1993; Nicholson et al. 1997; Carrat et al.
1999); (2) lower respiratory tract symptoms were reported
to complicate 65 % of upper respiratory tract infections
(Nicholson et al. 1997). For each past episode of acute
respiratory infection, information on illness severity, i.e.
staying in bed (in bed for several hours because of infec-
tion-related symptoms at a time that one would not usually
stay in bed), medical consultation (visit a general prac-
titioner or other physician because of infection-related
symptoms) and use of medication (any medication, includ-
ing antibiotics, prescribed by a general practitioner or other
physician), were also recorded in the questionnaire.
Analysis of carotenoids
Between 1 September 1998 and 23 March 1999 blood
samples were drawn to determine the plasma concen-
trations of cis-b-carotene, trans-b-carotene, a-carotene,
b-cryptoxanthin, lycopene, lutein and zeaxanthin. The
b-carotene concentration was calculated from the sum of
cis-b-carotene and trans-b-carotene values. Concentrations
of retinol, a-tocopherol and ascorbic acid were also deter-
mined. Samples were collected between 08.30 and 11.00
hours. A light breakfast, without salads, fruits or fruit
juices, was allowed before sampling. None of the subjects
had been taking any nutritional supplementation in the 2
months before blood drawing. Plasma was immediately
stored on ice in a closed box, and, within 6 h of blood col-
lection, stored at 2808C. The reversed-phase HPLC
method was used to analyse fat-soluble vitamin concen-
trations (Hess et al. 1991; Aebischer et al. 1999). Ascorbic
acid concentration was obtained via standard procedures
and assessed by fluorimetric assay (Vuilleumier & Keck,
1989).
Statistical analyses
Participants were divided into quartiles of plasma caroten-
oid concentrations. The two middle quartiles, i.e. 25–75th,
were collapsed and referred to as ‘intermediate carotenoid
status’. The low-carotenoid class was taken as the refer-
ence group. Frequencies including percentages were calcu-
lated for categorical data and were compared by x 2 test or
Fisher’s exact test. Continuous variables were compared by
ANOVA for unbalanced data by the SAS procedure GLM
(SAS version 8; SAS Institute, Cary, NC, USA) and were
expressed as mean values and standard deviations.
To calculate incidence rate ratios of the infections, a
Poisson regression model was used with the number of epi-
sodes as the dependent variable and the carotenoid status as
the independent variable included in the model. Because
some carotenoids possess pro-vitamin A activity, the
relationship between vitamin A (retinol) and incidence of
the infections was assessed.
Because we assumed that all carotenoids could have the
same beneficial effect on the infections, all carotenoids
were combined in a Poisson regression model to investi-
gate whether the relative risk of such combination differed
from the results of b-carotene only.
Logistic regression was used to calculate adjusted odds
ratios and the corresponding 95 % CI for the severity out-
comes. Illness severity was assessed in participants who
experienced at least one acute respiratory infection.
The variables age, BMI, self-rated health (score 1–10,
10 indicating highest self-rated health), retinol, a-toco-
pherol and ascorbic acid status, gender, chronic obstructive
pulmonary disease, asthma, influenza vaccination, history
of nutritional supplementation and smoking (current,
former, never) were evaluated for confounding and effect
modification. If variables were related to the carotenoid
status and to the incidence of infection, they were entered
into the model. Depending on the carotenoid investigated,
gender, age, BMI, self-rated health and chronic obstructive
pulmonary disease turned out to be confounders. Inclusion
of age or gender into the models precluded adjustment for
BMI, because of multicollinearity between gender or age
and BMI. No effect modifiers turned out to influence the
relationships.
Results
Population characteristics and plasma (pro-) vitamin con-
centrations of participants at high, intermediate and low
b-carotene status are described in Table 1. Similar charac-
teristics were observed for the a-carotene, b-crypto-
xanthin, lycopene, lutein and zeaxanthin, and are
therefore not shown. The correlation between b-carotene
and a-carotene was 0·78 and between zeaxanthin and
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lutein 0·77. Correlations between the remaining caroten-
oids ranged from 0·19 to 0·48.
Of the 652 participants, 5·2 % chronically used multivita-
min–mineral supplementation, 0·2 % vitamin A and vitamin
A plus D, 3·5 % vitamin C and 1·2 % vitamin E. The last 2
months of the observation period (2 months before blood-
drawing) all participants refrained from any nutritional sup-
plementation because of the upcoming intervention.
In total, 417 participants reported 754 events of common
cold, 118 events of influenza, 108 events of sore throat, 43
events of pain in facial sinuses and 30 events of pneumo-
nia. These events were combined to 1053 acute respiratory
infections, which was the outcome in our present analysis.
In 26 % (n 235) of subjects there were no reports of
respiratory infection during the previous 1 year. On aver-
age, 1·6 episodes were recorded per person per year.
A statistically significant inverse relationship was
observed between b-carotene status and the incidence
rate, but not severity, of the infections (Table 2). We
observed a tendency for a similar relationship between
the incidence rate of respiratory infections and a-carotene
status and b-cryptoxanthin status. The incidence rate ratios
at high and intermediate concentrations were 0·79 (95 % CI
0·60–1·02) and 0·82 (95 % CI 0·66–1·01) for a-carotene
and 0·83 (95 % CI 0·64–1·07) and 0·78 (95 % CI 0·63–
0·97) for b-cryptoxanthin. When combinations of b-caro-
tene, a-carotene and b-cryptoxanthin were entered into
one model, b-carotene turned out to have the greatest
Table 2. Incidence and severity of acute respiratory infections according to plasma b-carotene concentration in
elderly Dutch subjects from 1997 to 1998*
b-Carotene concentration
High Intermediate Low
Outcomes† n OR 95 % CI OR 95 % CI OR P for trend
Incidence rate (per person per year) 652 1·66 1·73 2·34
Incidence rate ratio 0·71 0·54, 0·92 0·74 0·60, 0·91 1·00 0·01
Staying in bed‡ 417 0·74 0·38, 1·44 1·20 0·71, 2·03 1·00 .0·2
Medical consultation‡ 417 1·27 0·62, 2·61 1·44 0·79, 2·64 1·00 .0·2
Episode-related medication‡ 417 1·33 0·73, 2·43 1·60 0·96, 2·68 1·00 .0·2
OR, Odds ratio.
* For details of subjects and procedures, see Table 1 and p. 114.
† All outcomes were corrected for gender, age, self-rated health and chronic obstructive pulmonary disease.
‡ Adjusted OR (95 % CI) of variables indicating infection severity, i.e. fever, staying in bed, medical consultation and use of medication
were assessed in participants who experienced at least one respiratory infection (103 subjects in the high-, 206 in the intermediate-,
and 108 in the low-b-carotene group).
Table 1. Population characteristics and plasma concentrations of carotenoids and vitamins in 652 elderly
Dutch subjects by b-carotene concentration*
(Mean values and standard deviations)
High (n 162)
Intermediate
(n 325) Low (n 165)
b-Carotene. . . Mean SD Mean SD Mean SD
Population characteristics
Men (%) 37·0 47·1 67·9
Age (years) 74·0 7·1 73·6 6·9 72·2 6·7
BMI (kg/m2) 25·9 3·3 27·5 3·4 28·4 3·7
Self-rated health (score 1 (lowest)–10) 7·6 0·9 7·5 1·1 7·2 1·2
Chronic obstructive pulmonary disease (%) 4·3 9·5 17·0
Asthma (%) 1·9 2·8 1·8
Allergy (%)† 17·3 20·0 18·2
Current smoker (%) 8·0 9·9 14·6
Influenza vaccination (%) 75·2 74·9 75·2
Plasma vitamins (mmol/l)
b-Carotene 0·83 0·33 0·40 0·09 0·18 0·05
a-Carotene 0·15 0·12 0·07 0·04 0·04 0·02
b-Cryptoxanthin 0·43 0·33 0·30 0·21 0·18 0·13
Lycopene 0·43 0·27 0·28 0·19 0·19 0·14
Lutein 0·32 0·16 0·25 0·12 0·21 0·11
Zeaxanthin 0·07 0·03 0·06 0·03 0·05 0·02
Retinol 1·98 0·45 2·03 0·46 2·01 0·50
a-Tocopherol 31·4 7·1 29·4 6·1 26·9 6·6
Ascorbic acid 55·0 20·4 49·2 20·8 44·8 22·8
* For details of procedures, see p. 114.
† Allergy against pollen grains, domestic pets or house-dust.
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relative importance (results not shown). No significant
relationship was observed between the variables indicating
infection severity and a-carotene or b-cryptoxanthin status.
P values of tests for trend for the severity variables showed
no significant results.
The incidence rate ratios at high and intermediate con-
centrations were 1·24 (95 % CI 0·96–1·61) and 1·11
(95 % CI 0·89–1·40) for lycopene status, 1·13 (95 % CI
0·86–1·48) and 1·10 (95 % CI 0·88–1·40) for lutein
status, and 1·06 (95 % CI 0·83–1·35) and 0·92 (95 % CI
0·74–1·15) for zeaxanthin status. Correspondingly, no sig-
nificant relationship was observed between the variables
indicating infection severity and lycopene, lutein and zeax-
anthin status. P values for tests for trend for the severity
variables showed no significant results. Additional analysis
to investigate the relationship between retinol (vitamin A)
and the incidence of acute respiratory infections showed
that the incidence rate ratio was 1·00 (0·77–1·30) for
high v. low retinol status and 0·98 (95 % CI 0·79–1·24)
for intermediate v. low retinol status.
Discussion
In our large observational analysis in elderly people, a high
plasma b-carotene status was associated with a lower inci-
dence of acute respiratory infections, but not with a lower
illness severity. No relationship was observed between
plasma a-carotene, b-cryptoxantin, lycopene, lutein and
zeaxanthin status and the incidence and severity of the
infections.
In the following discussion, we will address the possible
threats to the internal validity in our present study. Error in
the assessment of both exposure and outcome may lead to
information bias. Participants and investigators were una-
ware of the carotenoid status at the time of outcome assess-
ment, which makes differential error in the assessment of
respiratory infections unlikely. Any error in the assessment
of carotenoid concentrations and infectious diseases is
expected to have been non-differential and could therefore
only have led to underestimation of the association. One
might wonder whether the plasma carotenoid concentration
of elderly people is stable over a 1-year period.
Van-Kappel et al. (2001) have shown that serum caroten-
oids were highly reproducible between 1- and 2-year
repeated measurements. We therefore have no reason to
question the representativeness of the observed concen-
trations for the previous year.
Incidence in this retrospective study was in accordance
with incidences reported in prospective studies that were
effectively validated by nurse or general practitioner
assessment, or by microbiological analyses (Falsey et al.
1995; Nicholson et al. 1997; Graat et al. 2002). Although
we cannot rule out misclassification of the self-recorded
infections, e.g. exacerbations of chronic obstructive pul-
monary disease could have been indistinguishable from
symptoms during respiratory infections, this supports the
accuracy of self-reporting of infections that occurred
during the previous 1 year.
Bias by confounding was appropriately addressed during
the data analysis phase. Multivariate analyses were
adjusted for several confounders. Bias might have occurred
by some variables that we did not measure, e.g. intake of
fruits and vegetables, and cognitive function.
The average plasma carotenoid concentrations and cor-
responding standard deviations as measured in our present
population were similar to levels in elderly Europeans,
except for the average lycopene concentration that was
higher in our present population (Haller et al. 1996). We
therefore suppose that our range of carotenoid concen-
trations was sufficiently large to show an effect.
We observed a beneficial association only for b-caro-
tene, and not for the other carotenoids. A high plasma
b-carotene concentration has been associated with
increased lung function (Grievink et al. 2000). Lung
tissue could be the relevant target tissue and plasma con-
centrations may serve as a more accessible biomarker of
carotenoid status of human lung tissue and broncho-alveo-
lar lavage cells (Redlich et al. 1996, 1998). Previous
research demonstrated quantifiable levels of various caro-
tenoids in human lung tissue, i.e. lutein, cryptoxanthin,
a-carotene, b-carotene and lycopene. The concentration
of b-carotene was higher compared with other carotenoids,
but it was not reported whether this was significant or not
(Schmitz et al. 1991). It is possible that our observed
favourable association of b-carotene was due to its
higher concentrations in lung tissue.
b-Carotene is a precursor of retinol. No clear favourable
effects of vitamin A supplementation on infectious disease
or immune response have been observed in elderly people
in developed countries, which is in accordance with our
present results (Murphy et al. 1992; Fortes et al. 1998).
Beneficial effects of vitamin A supplementation on infec-
tious diseases were predominantly observed in children
of developing countries; these children were sometimes
marginally deficient in vitamin A (Semba, 1994). Although
we cannot exclude the possibility that b-carotene is inver-
sely related to respiratory illness by influencing plasma
retinol concentration, we suppose that this mechanism is
less plausible.
We did not observe relationships between a-carotene,
b-cryptoxanthin, lycopene, lutein and zeaxanthin, and
acute respiratory infections. a-Carotene and b-crypto-
xanthin have never been reported in relation to incidence
or severity of acute respiratory infections, nor in relation to
human immune response. Literature concerning lycopene,
lutein and zeaxanthin, and immune function is scarce. No
clear associations of lycopene, lutein and zeaxanthin were
observed with blood monocytes and T-helper cell activities
(Jyonouchi et al. 1996; Hughes et al. 2000; Corridan et al.
2001). Correspondingly, no effect of tomato juice, with lyco-
pene being the predominant carotenoid, on cell-mediated
immunity was shown (Watzl et al. 2000). Those findings
support our null-findings on respiratory infections. In con-
trast, Watzl et al. (1999) showed improved T-lymphocyte
function by tomato juice consumption in subjects consuming
a diet low in carotenoids.
One may question whether information on plasma
carotenoid concentration can be extrapolated to the intake
of certain foods. Some studies have shown a significant
relationship between dietary intake of fruits and vegetables
and plasma carotenoid concentration (Rock et al. 1997;
Broekmans et al. 2000), whereas others did not
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(Tucker et al. 1999; Jansen, 2001; van-Kappel et al. 2001).
Fruits and vegetables do not only possess carotenoids, but
also various other bioactive compounds such as flavonoids.
If it had consistently been shown that a strong relationship
exists between intake of fruits and vegetables and plasma
carotenoid concentrations, we might have translated our
findings into dietary advice. Because of inconsistency in
the literature, such extrapolation is not possible.
Our present findings suggest that elderly persons with a
high plasma b-carotene concentration may have a lower
occurrence of acute respiratory infections. It would be
interesting to evaluate the effect of fruits and vegetables
or b-carotene supplementation on the infections in a trial.
However, one should be cautious about high-dose b-caro-
tene supplementation, since increased mortality has been
reported after such supplementation.
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